Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH-a add-back therapy after conservative surgery for moderate to severe endometriosis
ChiCTR2000030682Phase 4Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol, progesterone and gonadotropin-releasing hormone agonist in endometriosis (3 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: Kupperman score, Estrogen and 2 more. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
estradiolprogesteronegonadotropin-releasing hormone agonist
03
Conditions
endometriosis
Beyond the preview
Go deeper on ChiCTR2000030682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030682.